Posts Tagged: "stem cells"

Genetic and Stem Cell Therapies to Treat Cancers

There are certainly some signs for hope. One of them came recently from Princeton University, where graduate students worked on a project which identified a treatment for blocking an enzyme which is important for metastasis, or the spread of cancer through a patient’s body. Many methods of treating cancers can be incredibly damaging to a patient’s body. Today there are many cancer treatments that are developed with an eye towards minimizing the difficult side effects caused by a regimen of chemotherapy or radiation.

Samsung innovates in gene therapies and 3D content display

There have been signs that Samsung is trying to wind down its operations in its medical device businesses, but we found plenty of patent applications filed with the USPTO indicating that healthcare innovation is still very important to this corporation. A technique for the genetic analysis of human subjects to test for diagnosing certain leukemias is featured by U.S. Patent Application No. 20150038360, titled Method for Multiplex-Detecting Chronic Myelogenous Leukemia Gene Using Cleavable Probe. The kit for detecting an e19a2 breakpoint of a BCR-ABL fusion gene claimed here contains five primer sets, each having a primer comprised of a specific nucleic acid. This kit provides for the early detection of chronic myelogenous leukemia, or CML, including rarer varieties of the disease.

The University of California patents treatments for cancer and Alzheimer’s disease

The University of California maintains a portfolio of 11,556 active patent grants. Patented technologies which are currently available for licensing through UC include laser scanners for eye tracking, cardiovascular disorder treatments and environmentally friendly water treatment techniques. In 2013, the Regents of the University of California were issued 399 patents by the U.S. Patent and Trademark Office, tied for 89th-most. A great percentage of UC’s 2014 inventions were related to providing methods involving nucleic acids, host cells and pharmaceutical compositions.

Hewlett-Packard invents: From innovative inks to stem cell research

A number of patent applications recently published by the U.S. Patent and Trademark Office show an HP focus on ink products, including one electronic ink for use in digital displays that maintains an image while entering a low charge state. A few other attention grabbing patent applications disclose improvements in stem cell research as well as a mass spectrometry system for complying with federal regulations regarding metals mined from global areas experiencing civil unrest.

US, Europe Debate Embryonic Stem Cell Patents and Research

Earlier today the United States Court of Appeals for the District of Columbia vacated the preliminary injunction issued by the United States District Court for the District of Columbia preventing the federal government from funding stem cell research. Meanwhile, the patenting of stem cells is also currently under attack in Europe. According to European Union Advocate General M. Yves Bot, stem cells have the capacity to evolve into a complete human being and, therefore, must be legally classified as human embryos and must be excluded from patentability on moral grounds. But is it really moral not to perform research that many believe could hold promising cures for such diseases as Parkinson’s and Alzheimer’s?